Bridge Biotherapeutics (KQ288330) today announced the first patient dosing of BBT-401 in its open label, proof…
Category: Health
[featured-content cat_id=”36″]
[featured-content-slider cat_id=”36″]
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA)…
Vivera Pharmaceuticals Granted Allowance for ZICOH® Patent
Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent…
One-Year Anniversary of Pandemic Is Remembered Through Giving Back and Humanitarian Efforts From It Works!
Mark Pentecost, It Works! CEO and entrepreneur, advocates for philanthropy now more than ever as communities look to…
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA
Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical…
Tivity Health to Participate in Upcoming Investor Conferences
Tivity Health, Inc. (NASDAQ: TVTY) today announced that it will participate in the following virtual investor conferences:…
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central…
Oncopeptides presents clinical abstracts on melflufen at the 2021 American Society of Clinical Oncology
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies…
Medline Launches REFLEX™ Nitinol Staple System to Enhance Surgical Patient Outcomes
Attendees at this year’s American College of Foot & Ankle Surgeons (ACFAS) Scientific Conference in Las Vegas will…
California Family Physicians Applaud Expansion of COVID-19 Vaccine to Adolescents
California authorized the Pfizer vaccine for kids ages 12-15. The move came after a group of experts…